Diflucan and oncomychosis

Fluconazole User Reviews for Onychomycosis, Toenail at

In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.

Diflucan onychomycosis - Medical information and advice

Medscape uses cookies to customize the site based on the information we collect at registration.

Once-weekly fluconazole 150, 300, or 450 mg in the treatment of.

Fluconazole for onychomycosis - MedHelp diflucan

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate. Total dystrophic onychomycosis, the most advanced form of any subtype, presents as a thickened, opaque, and yellow-brown nail. Onychomycosis (OM) refers to a fungal infection that affects the toenails or the fingernails.

Onychomycosis Clinical Considerations and Recommendations

Applies to the following strength(s): 200 mg/100 m L-0.9% ; 400 mg/200 m L-0.9% ; 50 mg ; 100 mg ; 200 mg ; 200 mg/100 m L-5% ; 400 mg/200 m L-5% ; 10 mg/m L ; 40 mg/m L ; 150 mg ; 100 mg/50 m L-Na Cl 0.9% The information at is not a substitute for medical advice. 150 mg orally as a single dose Infectious Diseases Society of America (IDSA) Recommendations: -Uncomplicated vaginitis: 150 mg orally as a single dose -Management of recurrent vulvovaginal candidiasis (after 10 to 14 days induction therapy): 150 mg orally once a week for 6 months -Complicated vulvovaginal candidiasis: 150 mg orally every 72 hours for 3 doses US CDC Recommendations: -Uncomplicated vulvovaginal candidiasis: 150 mg orally as a single dose -Initial therapy for recurrent vulvovaginal candidiasis: 100 to 200 mg orally every 72 hours for 3 doses -Maintenance therapy for recurrent vulvovaginal candidiasis: 100 to 200 mg orally once a week for 6 months -Severe vulvovaginal candidiasis: 150 mg orally every 72 hours for 2 doses US CDC, National Institutes of Health (NIH), and IDSA Recommendations for HIV-infected Patients: -Uncomplicated vulvovaginal candidiasis: 150 mg orally as a single dose -Severe or recurrent vulvovaginal candidiasis: 100 to 200 mg orally once a day for at least 7 days -Suppressive therapy for vulvovaginal candidiasis: 150 mg orally once a week Comments: -Recommended as preferred therapy -Unless frequent or severe recurrences, suppressive therapy generally not recommended Oropharyngeal candidiasis: 200 mg IV or orally on the first day followed by 100 mg IV or orally once a day Duration of therapy: At least 2 weeks, to reduce the risk of relapse IDSA Recommendations: -Moderate to severe oropharyngeal candidiasis: 100 to 200 mg IV or orally once a day for 7 to 14 days Comments: -Recommended as primary therapy US CDC, NIH, and IDSA Recommendations for HIV-infected Patients: -Initial episodes of oropharyngeal candidiasis: 100 mg orally once a day for 7 to 14 days -Suppressive therapy for oropharyngeal candidiasis: 100 mg orally once a day or 3 times a week Comments: -Recommended as preferred oral therapy -Unless frequent or severe recurrences, suppressive therapy generally not recommended Doses up to 400 mg/day have been used.


Diflucan and oncomychosis:

Rating: 94 / 100

Overall: 100 Rates